APA (7th ed.) Citation

Kripp, M., & Hofheinz, R. (2017). AIO LQ-0110: A randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer. OncoTarget, 8(62), . https://doi.org/10.18632/oncotarget.21249

Chicago Style (17th ed.) Citation

Kripp, Melanie, and Ralf-Dieter Hofheinz. "AIO LQ-0110: A Randomized Phase II Trial Comparing Oral Doxycycline Versus Local Administration of Erythromycin as Preemptive Treatment Strategies of Panitumumab-mediated Skin Toxicity in Patients with Metastatic Colorectal Cancer." OncoTarget 8, no. 62 (2017). https://doi.org/10.18632/oncotarget.21249.

MLA (9th ed.) Citation

Kripp, Melanie, and Ralf-Dieter Hofheinz. "AIO LQ-0110: A Randomized Phase II Trial Comparing Oral Doxycycline Versus Local Administration of Erythromycin as Preemptive Treatment Strategies of Panitumumab-mediated Skin Toxicity in Patients with Metastatic Colorectal Cancer." OncoTarget, vol. 8, no. 62, 2017, https://doi.org/10.18632/oncotarget.21249.